Inhibitors of glucose-6-phosphate dehydrogenase for treating cardiovascular and pulmonary conditions
AssigneeIchor, LLC
InventorSachin A. GUPTE
Life of this patent
Estimating the term…
Abstract
The present disclosure provides for methods of treating or preventing a cardiovascular disorder and/or a related pulmonary disorder in a subject. In certain embodiments, the method comprises administering a therapeutically effective amount of an inhibitor of Glucose-6-phosphate dehydrogenase (G6PD), or a pharmaceutically acceptable salt, non-salt amorphous form, solvate, poly-morph, tautomer or prodrug thereof.
Claims11
A method for treating or preventing a cardiovascular disorder and/or a pulmonary disorder in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of an inhibitor of Glucose-6-phosphate dehydrogenase (G6PD), or a pharmaceutically acceptable salt (crystal and/or amorphous), non-salt amorphous form, solvate, poly-morph, tautomer or prodrug thereof.
Use of a compound having the formula of Formula I, Formula II, Formula III, Formula IV, Formula V, Formula IV, Formula VII, or Formula VIII, or any combination thereof, or a pharmaceutically acceptable salt (crystal and/or amorphous), non-amorphous form, solvate, poly-morph, tautomer or prodrug thereof in the preparation of a pharmaceutical composition for treating or preventing a cardiovascular disorder and/or a pulmonary disorder in a subject in need thereof.
Dependencies are inferred from the claim text.